About
AposHealth is developing solutions for the identification and treatment of gait-related conditions. The AposHealth foot-worn Apos3 device is FDA cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA-cleared wellness device that can help patients live well with other gait-related conditions such as chronic low back and hip pain. With a mission to advance global health through the power of movement, AposHealth's latest business unit, AposIQ, combines innovative technology, data science, and over a decade of experience in gait modification to determine the optimal way to adjust patients' gaits over time.
Funding history · 5 rounds · $37.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is AposHealth's primary focus?
- AposHealth develops solutions for the identification and treatment of gait-related conditions, including knee osteoarthritis, chronic low back, and hip pain.
- What is the regulatory status of AposHealth's Apos3 device?
- The AposHealth foot-worn Apos3 device is FDA cleared for treating knee osteoarthritis to temporarily reduce knee pain and improve lower extremity function. It is also available as a non-FDA-cleared wellness device for other gait-related conditions.
- When was AposHealth founded and where is its headquarters located?
- AposHealth was founded in January 2004 and is headquartered in Herzliya, Israel.
- How much funding has AposHealth raised in total?
- AposHealth has raised a total of $37 million across multiple funding rounds. For a full financing history, please refer to startupim.
- Which investors participated in AposHealth's Series A funding rounds?
- Notable investors in AposHealth's Series A funding rounds include Pitango VC, Aviv Venture Capital, Invus, and aMoon Fund.
- What was AposHealth's most recent funding round?
- AposHealth's most recent funding round was a Series A extension in February 2020, which raised $11 million.
- In which geographic markets does AposHealth operate?
- AposHealth operates in the United Kingdom, United States, and Singapore.
- What is AposHealth's employee count?
- AposHealth has an employee count ranging from 51 to 200, with an exact count of 116 employees.
- What is AposIQ, AposHealth's latest business unit?
- AposIQ is AposHealth's latest business unit, which combines innovative technology, data science, and over a decade of experience in gait modification to determine optimal gait adjustments for patients over time.
- What was a significant partnership announced by AposTherapy in May 2020?
- In May 2020, Apos Medical Assets partnered with Spirit Access to decrease the cost of knee pain treatments in the UK.